targeting egfr to enhance nkt cell-mediated killing of lung cancer cells
Published 1 year ago • 319 plays • Length 41:19Download video MP4
Download video MP3
Similar videos
-
59:04
optimizing car structures to enhance efficacy in solid tumours
-
0:16
label-free live cell imaging: activated t-cell killing cancer cell
-
1:18
exploring neoadjuvant egfr-tkis in lung cancer
-
2:04
acquired resistance to osimertinib in t790m-positive nsclc
-
0:30
denise o'dea, np: use of tki therapy in patients with egrf exon 21 substitutions (l858r)
-
2:55
updates on ipsc-derived nk cells for the treatment of glioblastoma
-
0:16
activated t cell attacks a cancer cell
-
4:03
approaching a case of egfr non–small cell lung cancer
-
1:24
egfr tkis excite treatment landscape of egfr-mutant lung cancers
-
1:02
osimertinib for treatment of egfr lung cancer
-
1:42
dr. bazhenova on sequential use of immunotherapy and egfr tkis in lung cancer
-
4:25
egfr tkis for relapsed/refractory nsclc
-
19:28
managing t790-positive egfr-mutated nsclc
-
8:27
egfr-targeted therapy for squamous ncslc
-
29:09
feeder free expansion and closed wash and concentration of a clinically relevant number
-
4:07
chemotherapy with i-o therapy in egfr- or alk-mutated nsclc
-
13:06
managing t790-negative egfr-mutated nsclc
-
5:10
sequencing egfr-targeted therapies in nsclc